In bladder cancer, H3K18la upregulates the expression of the transcription factor Yin Yang 1 (YY1) and the Y-box binding protein 1 (YBX1), promoting resistance to cisplatin [109]. This evidence concerns the gene YY1 and urinary bladder carcinoma.